Curaleaf Holdings Files 6-K, Will Use Form 40-F

Ticker: CURLF · Form: 6-K · Filed: 2024-04-23T00:00:00.000Z

Sentiment: neutral

Topics: reporting, compliance, annual-report

TL;DR

Curaleaf filed a 6-K, confirming they'll use Form 40-F for their annual report.

AI Summary

Curaleaf Holdings, Inc. filed a Form 6-K on April 23, 2024, indicating it will file its annual report under Form 40-F. The filing includes a press release as Exhibit 99.1. The company's principal executive office is located in Vancouver, British Columbia, Canada.

Why It Matters

This filing signals Curaleaf's compliance with reporting requirements for Canadian companies listed in the US, providing an update on their annual reporting status.

Risk Assessment

Risk Level: low — This is a routine administrative filing confirming the form type for their annual report.

Key Players & Entities

FAQ

What is the purpose of this Form 6-K filing?

The Form 6-K is filed to indicate that Curaleaf Holdings, Inc. will file its annual report under cover of Form 40-F.

Which form will Curaleaf Holdings, Inc. use for its annual report?

Curaleaf Holdings, Inc. will use Form 40-F for its annual report.

When was this Form 6-K filed?

This Form 6-K was filed on April 23, 2024.

What is the address of Curaleaf's Principal Executive Office?

The address of Curaleaf's Principal Executive Office is 666 Burrard Street, Suite 1700, Vancouver, British Columbia V6C 2X8, Canada.

Who signed this report on behalf of Curaleaf Holdings, Inc.?

Peter Clateman, Chief Legal Officer, signed the report on behalf of Curaleaf Holdings, Inc.

From the Filing

0001756770-24-000027.txt : 20240423 0001756770-24-000027.hdr.sgml : 20240423 20240423161559 ACCESSION NUMBER: 0001756770-24-000027 CONFORMED SUBMISSION TYPE: 6-K PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20240423 FILED AS OF DATE: 20240423 DATE AS OF CHANGE: 20240423 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Curaleaf Holdings, Inc. CENTRAL INDEX KEY: 0001756770 STANDARD INDUSTRIAL CLASSIFICATION: MEDICINAL CHEMICALS & BOTANICAL PRODUCTS [2833] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 000000000 STATE OF INCORPORATION: A1 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 6-K SEC ACT: 1934 Act SEC FILE NUMBER: 333-249081 FILM NUMBER: 24865014 BUSINESS ADDRESS: STREET 1: 420 LEXINGTON AVENUE CITY: NEW YORK STATE: NY ZIP: 10170 BUSINESS PHONE: 781-451-0117 MAIL ADDRESS: STREET 1: 420 LEXINGTON AVENUE CITY: NEW YORK STATE: NY ZIP: 10170 FORMER COMPANY: FORMER CONFORMED NAME: LEAD VENTURES INC. DATE OF NAME CHANGE: 20181023 6-K 1 a6-kcover042224.htm 6-K Document UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of April, 2024 Commission File Number: 333-249081 Curaleaf Holdings, Inc. (Name of Registrant) 666 Burrard Street, Suite 1700, Vancouver, British Columbia V6C 2X8, Canada (Address of Principal Executive Office) Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F. Form 20-F ☐    Form 40-F ☒ SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. CURALEAF HOLDINGS, INC. (Registrant) Date: April 23, 2024 By: /s/ Peter Clateman Name: Peter Clateman Title: Chief Legal Officer EXHIBIT INDEX Exhibit Number Description 99.1 Press Release dated April 22 , 2024 EX-99.1 2 pressrelease042224.htm EX-99.1 Document Curaleaf Completes Acquisition of Northern Green Canada   Bolsters Company's Advantage in Several Key Emerging Markets, including Australia, New Zealand, Germany, Poland and the United Kingdom   NEW YORK, April 22, 2024 – Curaleaf Holdings, Inc. (TSX: CURA) (OTCQX: CURLF) ("Curaleaf" or the "Company"), a leading international provider of consumer cannabis products, announced today the closing of its acquisition of Northern Green Canada ("NGC"), a vertically integrated Canadian licensed cannabis producer focused primarily on expanding in the international market through its EU-GMP certification. The accretive acquisition amplifies the Company’s strategic advantage in established European markets including Germany, Poland and the United Kingdom and provides a foothold in the emerging markets of Australia and New Zealand.   Integrating NGC’s international operation will equip Curaleaf with a secure and consistent high quality, non-irradiated, indoor EU-GMP flower supply, essential to maintaining its leading positions in Germany, the United Kingdom and Poland.   “We are thrilled to welcome NGC formally to the Curaleaf family of global brands,” said Boris Jordan, Founder and Executive Chairman of Curaleaf. “This is an incredibly important deal for our international expansion strategy, as we’ll be able to bolster our supply of high quality EU-GMP certified flower immediately to key European markets as well as enter the fast-growing markets of Australia and New Zealand.”   The global cannabis market is projected to generate $55 billion in sales by 2027. Emerging markets beyond the United States and Canada, including Germany, Australia and New Zealand are expected to contribute $6.3 billion of the $55 billion projection.   Terms of the acquisition of NGC include an initial payment at closing of

View on Read The Filing